Stockscreener 앱 받기
535.54
0.23%
1.23
전일 마감가:
$534.31
열려 있는:
$530.38
하루 거래량:
760.40K
Relative Volume:
1.29
시가총액:
$43.07B
수익:
$3.93B
순이익/손실:
$894.97M
주가수익비율:
49.50
EPS:
10.82
순현금흐름:
$837.70M
1주 성능:
-5.25%
1개월 성능:
-1.31%
6개월 성능:
+26.89%
1년 성능:
+12.08%
1일 변동 폭
$527.81
$539.11
1주일 범위
$527.81
$579.47
52주 변동 폭
$356.14
$579.47
아이덱스 래버러토리스 Stock (IDXX) Company Profile
명칭
Idexx Laboratories Inc
전화
(207) 556-0300
주소
ONE IDEXX DRIVE, WESTBROOK, ME
IDXX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
IDXX
Idexx Laboratories Inc
|
535.54 | 42.97B | 3.93B | 894.97M | 837.70M | 10.82 |
|
TMO
Thermo Fisher Scientific Inc
|
463.04 | 176.55B | 43.21B | 6.58B | 6.17B | 17.29 |
|
DHR
Danaher Corp
|
197.09 | 141.18B | 24.01B | 3.41B | 4.86B | 4.70 |
|
A
Agilent Technologies Inc
|
113.50 | 32.61B | 6.63B | 1.17B | 1.19B | 4.05 |
|
IQV
Iqvia Holdings Inc
|
182.45 | 31.60B | 15.50B | 1.33B | 2.16B | 7.34 |
아이덱스 래버러토리스 Stock (IDXX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-07-01 | 개시 | Jefferies | Buy |
| 2024-12-02 | 개시 | Leerink Partners | Outperform |
| 2024-07-25 | 개시 | BTIG Research | Buy |
| 2024-01-30 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2023-12-07 | 개시 | Exane BNP Paribas | Outperform |
| 2023-12-04 | 업그레이드 | Cleveland Research | Neutral → Buy |
| 2023-08-02 | 다운그레이드 | Atlantic Equities | Overweight → Neutral |
| 2022-07-25 | 다운그레이드 | Stifel | Buy → Hold |
| 2022-07-21 | 업그레이드 | Goldman | Neutral → Buy |
| 2022-07-12 | 개시 | Piper Sandler | Overweight |
| 2022-05-05 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2022-02-08 | 개시 | Atlantic Equities | Overweight |
| 2021-11-18 | 개시 | Morgan Stanley | Overweight |
| 2021-08-05 | 재개 | Credit Suisse | Outperform |
| 2021-07-12 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2021-02-17 | 개시 | Barclays | Overweight |
| 2019-09-09 | 개시 | Goldman | Neutral |
| 2019-05-23 | 개시 | Guggenheim | Buy |
| 2018-11-02 | 재확인 | BofA/Merrill | Buy |
| 2018-05-07 | 재확인 | Stifel | Buy |
| 2018-01-16 | 개시 | Piper Jaffray | Overweight |
| 2017-08-23 | 업그레이드 | BofA/Merrill | Neutral → Buy |
| 2017-07-28 | 업그레이드 | CL King | Neutral → Buy |
| 2017-02-03 | 다운그레이드 | Feltl & Co. | Hold → Sell |
| 2016-09-29 | 재개 | BofA/Merrill | Neutral |
| 2016-08-16 | 재확인 | Stifel | Buy |
| 2016-08-03 | 업그레이드 | Northcoast | Sell → Neutral |
| 2016-07-20 | 재확인 | Canaccord Genuity | Buy |
| 2016-04-19 | 재확인 | Canaccord Genuity | Buy |
| 2016-04-01 | 개시 | CL King | Neutral |
| 2016-03-21 | 재확인 | Stifel | Buy |
| 2016-02-04 | 개시 | Credit Suisse | Outperform |
| 2015-10-29 | 재확인 | Stifel | Buy |
| 2015-08-28 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2015-08-13 | 재확인 | Stifel | Buy |
| 2015-07-23 | 재확인 | Canaccord Genuity | Buy |
모두보기
아이덱스 래버러토리스 주식(IDXX)의 최신 뉴스
Earnings Outlook For IDEXX Laboratories - 富途牛牛
Is IDEXX Laboratories, Inc. (NASDAQ:IDXX) Worth US$534 Based On Its Intrinsic Value? - 富途牛牛
When is IDEXX Laboratories Inc. stock expected to show significant growthDaily Trading Forecasts From AI Tools - jammulinksnews.com
Should I hold or sell IDEXX Laboratories Inc. stock in 2025Earnings Report Outlook For 2025 - jammulinksnews.com
Excellent Execution Drove IDEXX Laboratories (IDXX) Shares Amid Macro Challenges - Insider Monkey
Emerging AI Technologies Unveiled by Chinese Academy of Engineering - AInvest
What are the latest earnings results for IDEXX Laboratories Inc.Financial News Tips For Beginners - jammulinksnews.com
Veterinary practice management software market to grow at a CAGR of 8% during the forecast period (2025 – 2030): Wissen Research - GlobeNewswire Inc.
IDEXX Releases 2024 Corporate Responsibility Report, Highlighting Progress Against Its Goals - The Malaysian Reserve
How high can IDEXX Laboratories Inc. stock price go in 2025Stock Market Entry Timing Signals Revealed - metal.it
IDEXX Revolutionizes Pet Cancer Detection, Helps 79,000 Animals in Latest ESG Milestone Report - Stock Titan
Leerink Raises PT on IDEXX Laboratories (IDXX) Stock - Insider Monkey
Why IDEXX Laboratories Inc. stock attracts strong analyst attentionRisk Controlled Picks With Real Returns Outlined - beatles.ru
RSI Crosses Above 30 for IDEXX Laboratories Inc. — Reversal in SightTop Performing Stock Insights Released Daily - metal.it
IDEXX Laboratories (IDXX) Rallied in Q2. Here’s Why - MSN
IDEXX to Release Q2 Earnings: What's in Store for the Stock? - MSN
What drove IDEXX's operating profit growth in Q3 2024? - AInvest
Is It Time To Consider Buying IDEXX Laboratories, Inc. (NASDAQ:IDXX)? - 富途牛牛
Volume Surge May Signal Institutional Interest in IDEXX Laboratories Inc.High Win Rate Trading Opportunities Detected - metal.it
Idexx Laboratories (IDXX) Earnings Expected to Grow: Should You Buy? - Yahoo Finance
What makes IDEXX Laboratories Inc. stock price move sharplyAchieve exceptional returns with expert guidance - jammulinksnews.com
What is the risk reward ratio of investing in IDEXX Laboratories Inc. stockUnstoppable trading performance - jammulinksnews.com
What is IDEXX Laboratories Inc. company’s growth strategyAchieve superior returns through strategic trading - jammulinksnews.com
How volatile is IDEXX Laboratories Inc. stock compared to the marketLightning-fast growth - jammulinksnews.com
IDEXX Laboratories Inc: Riding Strong on Robust Financials and Growth Potential - AInvest
IDEXX Laboratories, Inc. (IDXX): A Bull Case Theory - MSN
Is IDEXX Laboratories Inc. a good long term investmentSuperior trading gains - PrintWeekIndia
What analysts say about IDEXX Laboratories Inc. stockHigh-yield investments - Autocar Professional
IDEXX Laboratories Inc. Stock Analysis and ForecastUnstoppable profit momentum - Autocar Professional
What drives IDEXX Laboratories Inc. stock priceExplosive capital gains - Autocar Professional
Idexx Laboratories stock hits 52-week high at 549.81 USD By Investing.com - Investing.com South Africa
Idexx Laboratories stock hits 52-week high at 549.81 USD - Investing.com
At US$532, Is IDEXX Laboratories, Inc. (NASDAQ:IDXX) Worth Looking At Closely? - simplywall.st
Should You Consider Adding IDEXX Laboratories (IDXX) to Your Portfolio? - Insider Monkey
아이덱스 래버러토리스 (IDXX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.14%
0.55%
자본화:
|
볼륨(24시간):